---
title: "Astera's Q2 results draw positive reactions from analysts for Scorpio X lineup"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294972598.md"
description: "Astera Labs (ALAB) reported Q2 results that beat estimates, with analysts highlighting the positive reception of its new Scorpio X product line. Susquehanna raised its price target to $310 from $275, maintaining a Neutral rating. Despite the positive analyst sentiment, shares remained largely flat in premarket trading."
datetime: "2026-08-05T13:05:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294972598.md)
  - [en](https://longbridge.com/en/news/294972598.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294972598.md)
generator: "portal-rs"
---

# Astera's Q2 results draw positive reactions from analysts for Scorpio X lineup

Astera Labs (ALAB) second quarter results beat estimates, and analysts highlighted positives from the new product line Scorpio X. Shares of Astera Labs were largely flat premarket on Wednesday. Susquehanna increased its price target on Astera's stock to $310 from $275 while keeping a Neutral rating. "Reported 2Q26 revenue/EPS of $392 million/$0.80 ...

### Related Stocks

- [ALAB.US](https://longbridge.com/en/quote/ALAB.US.md)
- [LABX.US](https://longbridge.com/en/quote/LABX.US.md)

## Related News & Research

- [ALAB: Record Q2 revenue and Scorpio X-Series ramp drive strong growth outlook for Q3](https://longbridge.com/en/news/294883659.md)
- [Astera Labs' Post-Earnings Pullback May Be Last Chance to Buy Below $360](https://longbridge.com/en/news/295127470.md)
- [DataMEDS AI reports Q2 results](https://longbridge.com/en/news/296319297.md)
- [Grounded Lithium reports Q2 results](https://longbridge.com/en/news/296441438.md)
- [Calian Group Ltd. Just Recorded A 137% EPS Beat: Here's What Analysts Are Forecasting Next](https://longbridge.com/en/news/296027740.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**